1. Home
  2. Investing
  3. Stocks
  4. USA
  5. USOTC
  6. Algernon Pharmaceuticals Inc (QB) (AGNPF)
  7. Quote

AGNPF AGNPF

Algernon Pharmaceuticals (QB) Stock Price

0.0351
0.00 (0.0%)
0.0351
Volume 0.00
Bid Price 0.0315
Ask Price 0.0417
News -
Day High

Low
0.034

52 Week Range

High
0.43845

Day Low
Best deals to access real time data!
DDE w/Realtime (Monthly)
Monthly Subscription
for only
$34.10
Small Cap Pro
Monthly Subscription
for only
$49.05
Canna Trader Pro
Monthly Subscription
for only
$59.99
VAT not included
Company Name Stock Ticker Symbol Market Type
Algernon Pharmaceuticals Inc (QB) AGNPF OTCMarkets Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.0% 0.0351 19:00:00
Open Price Low Price High Price Close Price Prev Close
0.0351 0.0351
Last Trade Time Type Quantity Stock Price Currency
- 0 $ 0.0351 USD

Period:

Draw Mode:

Algernon Pharmaceuticals Inc (QB) Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 5.88M 167.49M 151.12M $ - $ - - -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
25.85k $ - - - -

more financials information »

Algernon Pharmaceuticals (QB) News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical AGNPF Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.000.000.000.0000.000.0%
1 Month0.06080.06080.0340.0436137612,221-0.0257-42.27%
3 Months0.08730.09290.0340.0553717308,736-0.0522-59.79%
6 Months0.120.141150.0340.0753903317,068-0.0849-70.75%
1 Year0.350.438450.0340.1872111584,786-0.3149-89.97%
3 Years0.040.48670.0340.2154443618,972-0.0049-12.25%
5 Years0.040.48670.0340.2154443618,972-0.0049-12.25%

Algernon Pharmaceuticals (QB) Description

Algernon Pharmaceuticals is a drug re-purposing company that investigates safe, already approved drugs for new disease applications, moving them efficiently and safely into new human trials, developing new formulations and seeking new regulatory approvals in global markets. Algernon specifically investigates compounds that have never been approved in the U.S. or Europe to avoid off label prescription writing.


Your Recent History
USOTC
AGNPF
Algernon P..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.